SCHEDULE 13D - SAMUEL D. ISALY

Company

BIOCRYST PHARMACEUTICALS INC

Filed

February 25, 2004

Accession Number

0000947871-04-000556

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →